Hoover Financial Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $16.3M | Sell |
45,435
-100
| -0.2% | -$35.9K | 2.9% | 8 |
|
|
2021
Q1 | $15.3M | Buy |
45,535
+3,208
| +8% | +$1.08M | 2.86% | 8 |
|
|
2020
Q4 | $12.6M | Sell |
42,327
-681
| -2% | -$203K | 3.15% | 8 |
|
|
2020
Q3 | $11.8M | Buy |
43,008
+161
| +0.4% | +$44.3K | 3.9% | 6 |
|
|
2020
Q2 | $9.73M | Sell |
42,847
-425
| -1% | -$96.6K | 3.73% | 6 |
|
|
2020
Q1 | $6.59M | Buy |
43,272
+2,714
| +7% | +$413K | 3.64% | 6 |
|
|
2019
Q4 | $6.1M | Sell |
40,558
-300
| -0.7% | -$45.1K | 2.98% | 7 |
|
|
2019
Q3 | $5.79M | Sell |
40,858
-780
| -2% | -$111K | 5.15% | 6 |
|
|
2019
Q2 | $5.21M | Sell |
41,638
-570
| -1% | -$71.3K | 4.79% | 6 |
|
|
2019
Q1 | $4.65M | Buy |
42,208
+107
| +0.3% | +$11.8K | 4.44% | 6 |
|
|
2018
Q4 | $4.13M | Buy |
+42,101
| New | +$4.13M | 4.55% | 6 |
|